InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: midastouch017 post# 3120

Sunday, 09/05/2021 6:38:55 PM

Sunday, September 05, 2021 6:38:55 PM

Post# of 3897
The company issued PR on 19th Jul - we are entering into 8th week. This is sufficient time for topline results. They may not have sub-group analysis.

If the topline results are good then they will try to get them out as soon as possible without sub-group analysis.

———-
/ July 19, 2021 / RedHill Biopharma Ltd. (NASDAQ:RDHL) ('RedHill' or the 'Company'), a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) [1] in patients hospitalized with severe COVID-19 pneumonia (NCT04467840).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News